Interact to see
Advertisement
Advertisement
JMKCX vs MEDFX
JMKCX vs MEDFX Comparison
Open Charts JMKCX vs MEDFX
JHancock Emerging Markets Debt C
Price$8.13
Change+$0.01 (+0.12%)
VolumeN/A
Net Assets1.15B
MFS Emerging Markets Debt R3
Price$12.65
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets7.63B
JMKCX vs MEDFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
JMKCX vs. MEDFX commentary
Nov 20, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMKCX is a Hold and MEDFX is a Hold.
FUNDAMENTALS
Fundamentals
MEDFX has more cash in the bank: 7.63B vs. JMKCX (1.15B). MEDFX (5.09) and JMKCX (4.87) have matching dividends . JMKCX was incepted earlier than MEDFX: JMKCX (11 years) vs MEDFX (17 years). JMKCX (1.89) is less costly to investors than MEDFX (1.07). MEDFX has a lower initial minimum investment than JMKCX: MEDFX (0) vs JMKCX (1000). MEDFX annual gain was more profitable for investors over the last year : 10.52 vs. JMKCX (9.52). MEDFX return over 5 years is better than : 10.44 vs. JMKCX (9.53).
| JMKCX | MEDFX | JMKCX / MEDFX | |
| Total Expense Ratio | 1.88 | 1.06 | 177% |
| Annual Report Gross Expense Ratio | 1.89 | 1.07 | 177% |
| Fund Existence | 11 years | 17 years | - |
| Gain YTD | 9.556 | 10.341 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.15B | 7.63B | 15% |
| Annual Yield % from dividends | 4.87 | 5.09 | 96% |
| Returns for 1 year | 9.52 | 10.52 | 90% |
| Returns for 3 years | 34.22 | 34.57 | 99% |
| Returns for 5 years | 9.53 | 10.44 | 91% |
| Returns for 10 years | 42.27 | 46.79 | 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement